These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24527807)

  • 1. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators.
    Piatnitski Chekler EL; Unwalla R; Khan TA; Tangirala RS; Johnson M; St Andre M; Anderson JT; Kenney T; Chiparri S; McNally C; Kilbourne E; Thompson C; Nagpal S; Weber G; Schelling S; Owens J; Morris CA; Powell D; Verhoest PR; Gilbert AM
    J Med Chem; 2014 Mar; 57(6):2462-71. PubMed ID: 24527807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications.
    Li JJ; Sutton JC; Nirschl A; Zou Y; Wang H; Sun C; Pi Z; Johnson R; Krystek SR; Seethala R; Golla R; Sleph PG; Beehler BC; Grover GJ; Fura A; Vyas VP; Li CY; Gougoutas JZ; Galella MA; Zahler R; Ostrowski J; Hamann LG
    J Med Chem; 2007 Jun; 50(13):3015-25. PubMed ID: 17552509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective androgen receptor modulator for hormonal male contraception.
    Chen J; Hwang DJ; Bohl CE; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2005 Feb; 312(2):546-53. PubMed ID: 15347734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activity.
    Long YO; Higuchi RI; Caferro TR; Lau TL; Wu M; Cummings ML; Martinborough EA; Marschke KB; Chang WY; López FJ; Karanewsky DS; Zhi L
    Bioorg Med Chem Lett; 2008 May; 18(9):2967-71. PubMed ID: 18400499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
    Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
    Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators.
    Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.
    Higuchi RI; Arienti KL; López FJ; Mani NS; Mais DE; Caferro TR; Long YO; Jones TK; Edwards JP; Zhi L; Schrader WT; Negro-Vilar A; Marschke KB
    J Med Chem; 2007 May; 50(10):2486-96. PubMed ID: 17439112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I.
    Aikawa K; Miyawaki T; Hitaka T; Imai YN; Hara T; Miyazaki J; Yamaoka M; Kusaka M; Kanzaki N; Tasaka A; Shiraishi M; Yamamoto S
    Bioorg Med Chem; 2015 May; 23(10):2568-78. PubMed ID: 25862209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 4-(hydroxymethyl)diarylhydantoin as a selective androgen receptor modulator.
    Nique F; Hebbe S; Triballeau N; Peixoto C; Lefrançois JM; Jary H; Alvey L; Manioc M; Housseman C; Klaassen H; Van Beeck K; Guédin D; Namour F; Minet D; Van der Aar E; Feyen J; Fletcher S; Blanqué R; Robin-Jagerschmidt C; Deprez P
    J Med Chem; 2012 Oct; 55(19):8236-47. PubMed ID: 22957947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator.
    Piu F; Gardell LR; Son T; Schlienger N; Lund BW; Schiffer HH; Vanover KE; Davis RE; Olsson R; Bradley SR
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):129-37. PubMed ID: 18164613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats.
    Gao W; Reiser PJ; Coss CC; Phelps MA; Kearbey JD; Miller DD; Dalton JT
    Endocrinology; 2005 Nov; 146(11):4887-97. PubMed ID: 16099859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of dimethandrolone 17β-undecanoate and 11β-methyl-19-nortestosterone 17β-dodecylcarbonate on body composition, bone mineral density, serum gonadotropins, and androgenic/anabolic activity in castrated male rats.
    Attardi BJ; Marck BT; Matsumoto AM; Koduri S; Hild SA
    J Androl; 2011; 32(2):183-92. PubMed ID: 20798389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-androgenic effects of S-40542, a novel non-steroidal selective androgen receptor modulator (SARM) for the treatment of benign prostatic hyperplasia.
    Nejishima H; Yamamoto N; Suzuki M; Furuya K; Nagata N; Yamada S
    Prostate; 2012 Oct; 72(14):1580-7. PubMed ID: 22430536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators.
    Unwalla R; Mousseau JJ; Fadeyi OO; Choi C; Parris K; Hu B; Kenney T; Chippari S; McNally C; Vishwanathan K; Kilbourne E; Thompson C; Nagpal S; Wrobel J; Yudt M; Morris CA; Powell D; Gilbert AM; Chekler ELP
    J Med Chem; 2017 Jul; 60(14):6451-6457. PubMed ID: 28696695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of diarylhydantoins as new selective androgen receptor modulators.
    Nique F; Hebbe S; Peixoto C; Annoot D; Lefrançois JM; Duval E; Michoux L; Triballeau N; Lemoullec JM; Mollat P; Thauvin M; Prangé T; Minet D; Clément-Lacroix P; Robin-Jagerschmidt C; Fleury D; Guédin D; Deprez P
    J Med Chem; 2012 Oct; 55(19):8225-35. PubMed ID: 22897611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel synthetic androgen receptor ligand, S42, works as a selective androgen receptor modulator and possesses metabolic effects with little impact on the prostate.
    Min L; Yanase T; Tanaka T; Fan W; Nomura M; Kawate H; Okabe T; Takayanagi R; Nawata H
    Endocrinology; 2009 Dec; 150(12):5606-16. PubMed ID: 19854864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats.
    Ostrowski J; Kuhns JE; Lupisella JA; Manfredi MC; Beehler BC; Krystek SR; Bi Y; Sun C; Seethala R; Golla R; Sleph PG; Fura A; An Y; Kish KF; Sack JS; Mookhtiar KA; Grover GJ; Hamann LG
    Endocrinology; 2007 Jan; 148(1):4-12. PubMed ID: 17008401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of selective androgen receptor modulators.
    Yin D; Gao W; Kearbey JD; Xu H; Chung K; He Y; Marhefka CA; Veverka KA; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1334-40. PubMed ID: 12604714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulators.
    Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Jan; 17(2):439-43. PubMed ID: 17079140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of potent and tissue-selective androgen receptor modulators (SARMs): 2-(2,2,2)-Trifluoroethyl-benzimidazole scaffold.
    Ng RA; Lanter JC; Alford VC; Allan GF; Sbriscia T; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1784-7. PubMed ID: 17197181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.